MaxCyte, Inc. Presents Unprecedented Data Using Flow Electroporation for CHO-Based Transient Gene Expression to Achieve Gram Scale Antibody Production and Rapid Stable Cell Line Generation
5/20/2013 10:55:23 AM
More...
|
MaxCyte, Inc. Presents Unprecedented Data Using Flow Electroporation for CHO-Based Transient Gene Expression to Achieve Gram Scale Antibody Production and Rapid Stable Cell Line Generation
5/20/2013 10:19:35 AM
More...
|
MaxCyte, Inc. CEO Doug Doerfler Named Chairman of the Tech Council of Maryland
5/17/2013 9:52:34 AM
More...
|
MaxCyte, Inc. Presents Unprecedented CHO-Based Transient Gene Expression Data for Gram Scale Antibody Production and Rapid Stable Cell Line Generation at CHI’s 2013 Protein and Antibody Engineering Summit (PEGS)
4/26/2013 9:09:49 AM
More...
|
MaxCyte, Inc.® VLX™ and STX™ Transient Transfection Systems Are Acquired by Paragon Bioservices for Use in Vaccine and Protein Manufacturing
1/29/2013 9:45:31 AM
More...
|
MaxCyte, Inc. Highlights Innovations in Scalable, High-Throughput Transient Transfection for Streamlining Antibody Development and Production at PepTalk 2013, Booth #307
1/22/2013 9:46:40 AM
More...
|
MaxCyte, Inc. Highlights Innovations in Scalable, High-Throughput Transfection for Cell-Based Assays at the SLAS2013 Conference and Exhibition in Orlando, Booth #428
1/11/2013 9:59:20 AM
More...
|
MaxCyte, Inc. Announces a Business & Technical Update at Biotech Showcase 2013
1/4/2013 9:06:07 AM
More...
|
MaxCyte, Inc. Highlights High Titer Protein Production Using Biologically Relevant Cells in an Upcoming Educational Webinar Presentation
12/11/2012 11:05:05 AM
More...
|
MaxCyte, Inc. Highlights Gram Scale Protein Production Capability Using CHO Transient Transfection in an Upcoming Educational Webinar Presentation
3/21/2012 6:01:40 AM
More...
|
|